Meet Our Team at CPHI

Dr. Abdelaziz Toumi CEO
Dr. Abdelaziz Toumi
Chief Executive Officer
Eduardo Jule
Eduardo Jule
Chief Commercial Officer
Dr. Rakesh Ganorkar Chief Scientific Officer
Dr. Rakesh Ganorkar
Chief Scientific Officer
Mark Hoggan
Mark Hoggan
VP - Business Development (EMEA)
Mahesh Kale
Mahesh Kale
Sr. GM - Business Development (APAC)
Robert Geiger VP, Business Development
Robert Geiger
VP - Business Development (North America)
Namrata Nangia
Namrata Nangia
Dy. GM - Business Development
Abhilasha Upadhyay
Abhilasha Upadhyay
Sr. Manager - Procurement

LMS in Numbers

300+
DMF Filings
250+
Scientists
3.23 Mn
Square feet total
facility area
50%
Energy requirement
fulfilled through
renewable
sources

Our Offerings

Complex Chemistry
  1. Multi-step synthesis
    Multi-step synthesis
  2. Chiral chemistry
    Chiral chemistry
  3. Scale-up and technology transfer
    Scale-up and technology transfer
  4. Commercial manufacturing
    Commercial manufacturing
High Potency APIs
  1. Dedicated HPAPI suites
    Dedicated HPAPI suites
  2. OEB-5 containment
    OEB-5 containment
  3. Oncology-focused programs
    Oncology-focused programs
  4. Development to commercial supply
    Development to commercial supply
Why LMS
  1. Icon representing business collaboration
    Integrated R&D and manufacturing
  2. Icon symbolizing pharmaceutical solutions
    Global regulatory experience
  3. Icon representing partnership and trust
    Development through commercialization
  4. Icon representing medical research
    Lupin-backed platform

About Lupin Manufacturing Solutions

Lupin Manufacturing Solutions (LMS) is a global Contract Development and Manufacturing
Organization (CDMO) offering standalone & integrated solutions across drug substance,
complex chemistry, drug product, and advanced modalities including ADCs and peptides.
Leveraging Lupin’s legacy of scientific rigor and regulatory expertise,
LMS supports biopharma innovators from early development to commercial scale. With
state-of-the-art facilities, a client-first approach, and a team of 250+ scientists,
LMS accelerates the path to market for transformative therapies.

LMS is where science meets speed,
and innovation meets execution.

For more details,
visit https://lmscdmo.com/ or write to us at lmsinfo@lupin.com

Backed by Lupin's
Legacy & Global Presence

World map graphic showing Lupin’s global presence

Let's Meet at CPHI